Cargando…

Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma

Overexpressed genes in tumors usually contributed to aggressiveness in pancreatic ductal adenocarcinoma (PDAC). Using Gene Expression Omnibus (GEO) profiles including GSE46234, GSE71989, and GSE107610, we detected overexpressed genes in tumors with R program, which were enriched by Kyoto Encyclopedi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Shu, Huang, Fei, Zhang, Hao, Chen, Qiwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390130/ https://www.ncbi.nlm.nih.gov/pubmed/30765611 http://dx.doi.org/10.1042/BSR20182306

Ejemplares similares

Coupling of Cdc20 inhibition and activation by BubR1
por: Hein, Jamin B., et al.
Publicado: (2021)

Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2020)

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
por: Chang, David Z, et al.
Publicado: (2012)

CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis
por: Li, Jianxin, et al.
Publicado: (2020)

Bub3–BubR1-dependent sequestration of Cdc20(Fizzy) at DNA breaks facilitates the correct segregation of broken chromosomes
por: Derive, Nicolas, et al.
Publicado: (2015)

CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis
por: Yang, Wan-Xia, et al.
Publicado: (2019)

Bub3 promotes Cdc20-dependent activation of the APC/C in S. cerevisiae
por: Yang, Yang, et al.
Publicado: (2015)

BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma
por: Hao, Qirong, et al.
Publicado: (2023)

The Bub1–Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation
por: Jia, Luying, et al.
Publicado: (2016)

Juxtaposition of Bub1 and Cdc20 on phosphorylated Mad1 during catalytic mitotic checkpoint complex assembly
por: Fischer, Elyse S., et al.
Publicado: (2022)

Defining the Molecular Basis of BubR1 Kinetochore Interactions and APC/C-CDC20 Inhibition
por: D'Arcy, Sheena, et al.
Publicado: (2010)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma
por: Bo, Wentao, et al.
Publicado: (2021)

CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
por: Wu, Wen-jing, et al.
Publicado: (2013)

Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway
por: Li, Ziheng, et al.
Publicado: (2021)

Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma
por: Long, Zeling, et al.
Publicado: (2021)

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
por: Fu, Xin, et al.
Publicado: (2016)

BUB1 and CENP-U, Primed by CDK1, Are the Main PLK1 Kinetochore Receptors in Mitosis
por: Singh, Priyanka, et al.
Publicado: (2021)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
por: Zhuang, Liping, et al.
Publicado: (2018)

Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer
por: Xing, Zeyu, et al.
Publicado: (2021)

High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Han, Hailin, et al.
Publicado: (2018)

MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma
por: Hu, Zhan-Dong, et al.
Publicado: (2019)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)
por: Wijnen, Rosa, et al.
Publicado: (2021)

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
por: Bose, Mukulika, et al.
Publicado: (2022)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2
por: Sudakin, Valery, et al.
Publicado: (2001)

ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
por: Zhang, Qiaoling, et al.
Publicado: (2022)

High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
por: Huo, Yanmiao, et al.
Publicado: (2015)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2018)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
por: Liu, Wen-Jing, et al.
Publicado: (2018)

Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Yamakawa, Kohei, et al.
Publicado: (2022)

SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells
por: Li, Tong, et al.
Publicado: (2020)

CCNA
por: Valentine, Michael, et al.
Publicado: (2008)

Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinoma
por: Chen, Honglin, et al.
Publicado: (2015)

Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7qma4i80hv942eov4dq0mf3k6d